A. Schilf

669 total citations
7 papers, 496 citations indexed

About

A. Schilf is a scholar working on Otorhinolaryngology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. Schilf has authored 7 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Otorhinolaryngology, 3 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. Schilf's work include Head and Neck Cancer Studies (4 papers), Lung Cancer Treatments and Mutations (2 papers) and Head and Neck Surgical Oncology (2 papers). A. Schilf is often cited by papers focused on Head and Neck Cancer Studies (4 papers), Lung Cancer Treatments and Mutations (2 papers) and Head and Neck Surgical Oncology (2 papers). A. Schilf collaborates with scholars based in France, Belgium and Spain. A. Schilf's co-authors include D. Machover, J. Vignoud, Albert Abad, Emmanuel Jean Francois, Érick Gamelin, Javier Sastre, Aimery de Gramont, M. Itzhaki, M. Marty and Jean‐François Seitz and has published in prestigious journals such as Annals of Oncology and Clinical Nutrition.

In The Last Decade

A. Schilf

6 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Schilf France	4	365	172	96	91	80	7	496
J. Vignoud France	9	693 1.9×	220 1.3×	168 1.8×	135 1.5×	68 0.8×	14	857
T.S. Maughan United Kingdom	10	212 0.6×	233 1.4×	170 1.8×	77 0.8×	51 0.6×	23	559
J McKendrick Australia	9	338 0.9×	180 1.0×	81 0.8×	96 1.1×	23 0.3×	24	525
A. Fandi France	6	292 0.8×	207 1.2×	108 1.1×	39 0.4×	47 0.6×	7	473
N. Anderson United States	10	240 0.7×	98 0.6×	151 1.6×	68 0.7×	39 0.5×	19	473
Elisabetta Alafaci Italy	4	473 1.3×	152 0.9×	185 1.9×	54 0.6×	24 0.3×	7	580
József Lövey Hungary	12	168 0.5×	153 0.9×	49 0.5×	34 0.4×	49 0.6×	46	406
Miah Hiang Tay Singapore	11	157 0.4×	207 1.2×	59 0.6×	64 0.7×	71 0.9×	23	437
Giuseppe De Cataldis Italy	8	529 1.4×	518 3.0×	49 0.5×	32 0.4×	17 0.2×	14	708
Ramón Barceló Spain	9	158 0.4×	159 0.9×	48 0.5×	29 0.3×	13 0.2×	28	293

Countries citing papers authored by A. Schilf

Since Specialization

Citations

This map shows the geographic impact of A. Schilf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Schilf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Schilf more than expected).

Fields of papers citing papers by A. Schilf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Schilf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Schilf. The network helps show where A. Schilf may publish in the future.

Co-authorship network of co-authors of A. Schilf

This figure shows the co-authorship network connecting the top 25 collaborators of A. Schilf. A scholar is included among the top collaborators of A. Schilf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Schilf. A. Schilf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Guigay, J., Jérôme Fayette, Anne-Françoise Dillies, et al.. (2015). Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study. Annals of Oncology. 26(9). 1941–1947. 100 indexed citations

Even, Caroline, François‐Régis Ferrand, François Bidault, et al.. (2014). Results of Tpex (Docetaxel, Cisplatin, Cetuximab) Regimen Use in First Line Patients with Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M Scchn) in a Single Institution. Annals of Oncology. 25. iv344–iv344. 2 indexed citations

Falewee, M.-N., A. Schilf, C. Cartier, et al.. (2013). Reduced infections with perioperative immunonutrition in head and neck cancer: Exploratory results of a multicenter, prospective, randomized, double-blind study. Clinical Nutrition. 33(5). 776–784. 25 indexed citations

Saâda, Esma, François‐Régis Ferrand, François Janot, et al.. (2012). Docetaxel, Carboplatin and Fluoro-Uracil (TCF) Induction Therapy in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) Patients with Contraindication for Cisplatin Based Combination (TPF). Annals of Oncology. 23. ix340–ix340.

Saâda, Esma, et al.. (2012). The Tolerance of TPF Chemotherapy Regime Standard or Modified in Head Neck Cancer Patients Over 65 Years Old. Annals of Oncology. 23. ix341–ix341. 1 indexed citations

Machover, D., Béatrice Delmas-Marsalet, Emma Goldschmidt, et al.. (2001). Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin’s lymphoma. Annals of Oncology. 12(10). 1439–1443. 37 indexed citations

Machover, D., Eduardo Díaz‐Rubio, Aimery de Gramont, et al.. (1996). Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines. Annals of Oncology. 7(1). 95–98. 331 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact